| [1] |
Daley CL, Iaccarino JM, Lange C, et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Clin Infect Dis, 2020, 71(4):e1-e36. doi:10.1093/cid/ciaa241.
|
| [2] |
Hoefsloot W, van Ingen J, Andrejak C, et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J, 2013, 42(6):1604-1613. doi:10.1183/09031936.00149212.
pmid: 23598956
|
| [3] |
刘盛盛, 唐神结. 《非结核分枝杆菌病诊断与治疗指南(2020年版)》解读. 结核与肺部疾病杂志, 2021, 2(2):108-115. doi:10.3760/cma.j.cn112147-20200508-00570.
|
| [4] |
Matsuyama M, Matsumura S, Nonaka M, et al. Pathophysio-logy of pulmonary nontuberculous mycobacterial (NTM) disease. Respir Investig, 2023, 61(2):135-148. doi:10.1016/j.resinv.2022.12.002.
pmid: 36640546
|
| [5] |
Matsuyama M, Nonaka M, Nakajima M, et al. The Role of NRF 2 in Mycobacterial Infection. Antioxidants (Basel), 2021, 10(12):1861. doi:10.3390/antiox10121861.
|
| [6] |
Cohn L, Herrick C, Niu N, et al. IL-4 promotes airway eosinophilia by suppressing IFN-gamma production: defining a novel role for IFN-gamma in the regulation of allergic airway inflammation. J Immunol, 2001, 166(4):2760-2767. doi:10.4049/jimmunol.166.4.2760.
pmid: 11160342
|
| [7] |
Honda JR, Virdi R, Chan ED. Global Environmental Nontuberculous Mycobacteria and Their Contemporaneous Man-Made and Natural Niches. Front Microbiol, 2018, 9:2029. doi:10.3389/fmicb.2018.02029.
pmid: 30214436
|
| [8] |
Falkinham JR. Current Epidemiologic Trends of the Nontuberculous Mycobacteria (NTM). Curr Environ Health Rep, 2016, 3(2):161-167. doi:10.1007/s40572-016-0086-z.
pmid: 27020801
|
| [9] |
Desai AN, Hurtado R. Nontuberculous Mycobacterial Infections. JAMA, 2021, 325(15):1574. doi:10.1001/jama.2020.19062.
pmid: 33877273
|
| [10] |
Dastranj M, Farahani A, Hashemi SA, et al. Molecular identification and distribution of non-tuberculous mycobacteria isolated from clinical specimens by PCR-sequencing method in West of Iran. Clin Respir J, 2018, 12(3):996-1002. doi:10.1111/crj.12617.
pmid: 28224727
|
| [11] |
Pfeffer PE, Hopkins S, Cropley I, et al. An association between pulmonary Mycobacterium avium-intracellulare complex infections and biomarkers of Th2-type inflammation. Respir Res, 2017, 18(1):93. doi:10.1186/s12931-017-0579-9.
|
| [12] |
Pavord ID, Agusti A. Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease. Eur Respir J, 2016, 47(5):1299-1303. doi:10.1183/13993003.00055-2016.
pmid: 27132257
|
| [13] |
Jasenosky LD, Scriba TJ, Hanekom WA, et al. T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol Rev, 2015, 264(1):74-87. doi:10.1111/imr.12274.
pmid: 25703553
|
| [14] |
周荣真, 吴秀丽, 王健, 等. 鸟-胞内分枝杆菌肺病伴空洞的CT特征分析. 中国防痨杂志, 2019, 41(9):1009-1014. doi:10.3969/j.issn.1000-6621.2019.09.018.
|
| [15] |
Kumar K, Daley CL, Griffith DE, et al. Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments. Eur Respir Rev, 2022, 31(163):210-212. doi:10.1183/16000617.0212-2021.
|
| [16] |
孔娇, 陈园园, 蔡青山, 等. 宏基因二代测序技术对非结核分枝杆菌肺病的诊断价值. 中国防痨杂志, 2022, 44(11):1135-1140. doi:10.19982/j.issn.1000-6621.20220298.
|
| [17] |
Emmi G, Bettiol A, Gelain E, et al. Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis. Nat Rev Rheumatol, 2023, 19(6):378-393. doi:10.1038/s41584-023-00958-w.
pmid: 37161084
|
| [18] |
Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum, 2013, 65(1):1-11. doi:10.1002/art.37715.
|
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
